1. Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-β/Smads signaling pathway
    Yichuan Xiao et al, 2018, Archives of Biochemistry and Biophysics CrossRef
  2. Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
    Monika Rech et al, 2018 CrossRef
  3. PPARα is Necessary for Radiation-Induced Activation of Non-Canonical TGFβ signaling in the Heart
    Vikram Subramanian et al, 2018, J. Proteome Res. CrossRef
  4. Molecular network, pathway, and functional analysis of time-dependent gene changes related to cathepsin G exposure in neonatal rat cardiomyocytes
    Sanket Kumar Shukla et al, 2018, Gene CrossRef
  5. Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis
    Zehua Li et al, 2018, Lab Invest CrossRef
  6. NLRP1 promotes TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts
    Jing Zong et al, 2018, J Mol Hist CrossRef
  7. Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice
    Sukka Santosh Reddy et al, 2018, Journal of Molecular and Cellular Cardiology CrossRef
  8. Hereditary Hemorrhagic Telangiectasia with SMAD4 Mutations is Associated with Fatty Degeneration of the Left Ventricle, Coronary Artery Aneurysm, and Abdominal Aortic Aneurysm
    Yasunori Inoguchi et al, 2019, Intern. Med. CrossRef
  9. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway
    Shuai Mao et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  10. Inhibitory Effects of Momordicine I on High-Glucose-Induced Cell Proliferation and Collagen Synthesis in Rat Cardiac Fibroblasts
    Po-Yuan Chen et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  11. Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice
    Mudit Mishra et al, 2018, IJMS CrossRef
  12. The Cellular Senescence-Inhibited Gene Is Essential for PPM1A Myristoylation To Modulate Transforming Growth Factor β Signaling
    Feng Zhu et al, 2018, Mol Cell Biol CrossRef
  13. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor
    Cheng-Bi Xu et al, 2019, J Cell Biochem CrossRef
  14. Stevioside attenuates isoproterenol-induced mouse myocardial fibrosis through inhibition of the myocardial NF-κB/TGF-β1/Smad signaling pathway
    Jia Wang et al, 2019, Food Funct. CrossRef
  15. A generally conserved response to hypoxia in iPSC-derived cardiomyocytes from humans and chimpanzees
    Michelle C Ward et al, 2019 CrossRef
  16. Pro-remodeling peptides modulate collagen α1(I) promoter activity in rat cardiac myofibroblasts
    Andrew Kisling et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  17. null
    Adina Elena Stanciu, 2019 CrossRef
  18. Current understanding of fibrosis in genetic cardiomyopathies.
    Tim R Eijgenraam et al, 2020, Trends Cardiovasc Med CrossRef
  19. Resveratrol Modulates miR-34a in Cardiotoxicity Induced by Isoproterenol
    Sylvia A. Boshra, 2019, Journal of Medicinal Food CrossRef
  20. Dissection of heterocellular cross-talk in vascularized cardiac tissue mimetics
    Julian Uwe Gabriel Wagner et al, 2019, Journal of Molecular and Cellular Cardiology CrossRef
  21. Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening
    Brian Yu et al, 2020, Expert Opinion on Therapeutic Targets CrossRef
  22. Assessment of vitamin D and inflammatory markers profile in cardiac tissue on Parkinson disease animal model
    Mariana Bocca Nejm et al, 2020, Pharmacol. Rep CrossRef
  23. A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5
    Thomas Hanke et al, 2020, ACS Chem. Biol. CrossRef
  24. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics
    David Ben-Nun et al, 2020, Cardiovascular Pathology CrossRef
  25. Established and Emerging Mechanisms in the Pathogenesis of Arrhythmogenic Cardiomyopathy: A Multifaceted Disease
    Shanshan Gao et al, 2020, IJMS CrossRef
  26. Coronary Microvascular Dysfunction
    Federico Vancheri et al, 2020, JCM CrossRef
  27. Single-Cell RNA-seq Analysis Reveals a Crucial Role for Collagen Triple Helix Repeat Containing 1 (CTHRC1) Cardiac Fibroblasts after Myocardial Infarction
    Adrian Ruiz-Villalba et al, 2020, Circulation CrossRef
  28. Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors
    Mouhamed Nashawi et al, 2020, Heart Fail Rev CrossRef
  29. Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling
    Naoko Yamaguchi et al, 2020, Circulation CrossRef
  30. Wnt3a upregulation is involved in TGFβ1-induced cardiac hypertrophy
    Tao Li et al, 2020, Cytokine CrossRef
  31. Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways
    Chang-yi Li et al, 2021, J. of Cardiovasc. Trans. Res. CrossRef
  32. Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
    Ajit Magadum et al, 2021, Adv. Sci. CrossRef
  33. Extracellular Vesicles from Mesenchymal Stromal Cells for the Treatment of Inflammation-Related Conditions
    Sean T. Ryan et al, 2021, IJMS CrossRef
  34. Bellidifolin Ameliorates Isoprenaline-Induced Myocardial Fibrosis by Regulating TGF-β1/Smads and p38 Signaling and Preventing NR4A1 Cytoplasmic Localization
    Hong-Xia Yang et al, 2021, Front. Pharmacol. CrossRef
  35. Vascular growth factors as potential new treatment in cardiorenal syndrome in diabetes
    Carlo Alberto Ricciardi et al, 2021, Eur J Clin Invest CrossRef
  36. Myocardial Fibrosis in the Pathogenesis, Diagnosis, and Treatment of Hypertrophic Cardiomyopathy
    Zeyi Cheng et al, 2021, Cardiovascular Innovations and Applications CrossRef
  37. Novel factors that activate and deactivate cardiac fibroblasts: A new perspective for treatment of cardiac fibrosis
    Rebeca Oliveira Camargo et al, 2021, Wound Rep Reg CrossRef
  38. High carbohydrate intakes may predict more inflammatory status than high fat intakes in pre-menopause women with overweight or obesity: a cross-sectional study
    Elmira Karimi et al, 2021, BMC Res Notes CrossRef
  39. Nitro-Oleic Acid (NO2-OA) Improves Systolic Function in Dilated Cardiomyopathy by Attenuating Myocardial Fibrosis
    Simon Braumann et al, 2021, IJMS CrossRef
  40. Chronic Ethanol Exposure Induces Deleterious Changes in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells
    Rui Liu et al, 2021, Stem Cell Rev and Rep CrossRef
  41. Cambios moleculares en la remodelación cardiaca por síndrome metabólico.
    Misael Vargas López et al, 2020, Rev Cienc Biomed CrossRef
  42. Protection of CAPE-pNO2 Against Chronic Myocardial Ischemia by the TGF-Β1/Galectin-3 Pathway In Vivo and In Vitro
    Qin Wan et al, 2021, Inflammation CrossRef
  43. Cardiac ischemia on-a-chip to investigate cellular and molecular response of myocardial tissue under hypoxia
    Jaimeson Veldhuizen et al, 2021, Biomaterials CrossRef
  44. Exploring the multifaceted role of TGF-β signaling in diabetic complications
    Tapan Behl et al, 2022, Environ Sci Pollut Res CrossRef
  45. Angiotensin-(1–7) reduces doxorubicin-induced aortic arch dysfunction in male and female juvenile Sprague Dawley rats through pleiotropic mechanisms
    Omeed Rahimi et al, 2022, Peptides CrossRef
  46. miR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGFβRΙ and inhibiting the activation of Smad-2/3 pathway
    Xinyuan Han et al, 2022, J Bioenerg Biomembr CrossRef
  47. Fibro-fatty remodelling in arrhythmogenic cardiomyopathy
    Arwa Kohela et al, 2022, Basic Res Cardiol CrossRef
  48. Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure development
    Scott MacDonnell et al, 2022, Front. Cardiovasc. Med. CrossRef
  49. The Traditional Chinese Medicine Gedan Jiangya Decoction Alleviates Left Ventricular Hypertrophy via Suppressing the Ras/ERK1/2 Signaling Pathway
    Shadi A. D. Mohammed et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  50. The Innate Immune System in Cardiovascular Diseases and Its Role in Doxorubicin-Induced Cardiotoxicity
    Anchit Bhagat et al, 2022, IJMS CrossRef
  51. The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
    Kazuaki Maruyama et al, 2022, IJMS CrossRef
  52. Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study
    Toby Pillinger et al, 2023, The Lancet Psychiatry CrossRef
  53. Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy
    Konstantina Portokallidou et al, 2023, Front. Cardiovasc. Med. CrossRef
  54. Cardioprotective Effect of Flibanserin against Isoproterenol-Induced Myocardial Infarction in Female Rats: Role of Cardiac 5-HT2A Receptor Gene/5-HT/Ca2+ Pathway
    Mohamed I. Ahmed et al, 2023, Pharmaceuticals CrossRef
  55. Endothelial-derived extracellular vesicles from obese/hypertensive adults increase factors associated with hypertrophy and fibrosis in cardiomyocytes
    Hannah K. Fandl et al, 2023, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
  56. Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk
    Zhuojun Wu et al, 2023, Circulation Research CrossRef
  57. Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review
    Ming-Jui Hung et al, 2023, IJMS CrossRef
  58. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction
    Nassiba Menghoum et al, 2023, Platelets CrossRef
  59. Compromised diabetic heart function is not affected by miR-378a upregulation upon hyperglycemia
    Urszula Florczyk-Soluch et al, 2023, Pharmacol. Rep CrossRef
  60. Biosensors for natriuretic peptides in cardiovascular diseases. A review
    Mariana P. Sousa et al, 2023, Current Problems in Cardiology CrossRef
  61. Effects of Doxorubicin on Extracellular Matrix Regulation in Primary Cardiac Fibroblasts from Mice
    Cameron Skaggs et al, 2023, BMC Res Notes CrossRef
  62. Transforming growth factor-β and bone morphogenetic protein signaling pathways in pathological cardiac hypertrophy
    Jing Wen et al, 2024, Cell Cycle CrossRef
  63. Lrg1 silencing attenuates ischemia-reperfusion renal injury by regulating autophagy and apoptosis through the TGFβ1- Smad1/5 signaling pathway
    Jianhui Chen et al, 2024, Archives of Biochemistry and Biophysics CrossRef
  64. Fabry Disease: Cardiac Implications and Molecular Mechanisms
    David Weissman et al, 2024, Curr Heart Fail Rep CrossRef
  65. null
    Mohamed Mahmoud El-Sayed et al, 2024 CrossRef
  66. Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice
    Jeeyoung Lee et al, 2024, Front. Physiol. CrossRef